Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas | Communications Biology
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas | Communications Biology
Crosstalk among BC cells, glial cells, and the brain microenvironment.... | Download Scientific Diagram
IJMS | Free Full-Text | Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma | Nature Communications
Frontiers | Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood–Brain Barrier
The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain | Science Advances
Frontiers | Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
The blood–tumour barrier in cancer biology and therapy | Nature Reviews Clinical Oncology
Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy - ScienceDirect
Frontiers | Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery
Frontiers | Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner
Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma | Scientific Reports
IJMS | Free Full-Text | Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
Frontiers | Origin, activation, and targeted therapy of glioma-associated macrophages
Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation in: Vascular Biology Volume 2 Issue 1 (2020)
Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI | Scientific Reports
Frontiers | CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
Recombinant Human CCL2/MCP-1 Protein 279-MC-010: R&D Systems
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | American Journal of Physiology-Cell Physiology
Frontiers | Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood–Brain Barrier
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling | Cell Research
Smart Nanomedicine to Enable Crossing Blood–Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma | ACS Nano
Frontiers | Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | American Journal of Physiology-Cell Physiology
Frontiers | Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
